DR ELLIE: Why I fear thousands risk DYING after taking fat jabs: as 216 UK deaths are linked to the drugs, here's the precise diet, dose and other steps to cut the risk

A 19-year-old American law student living in London died after taking a weight-loss drug containing tirzepatide, the active ingredient in NHS-approved Mounjaro, according to reports. Josephine Nasr, from California, suffered a heart rhythm complication in her room at the University of East London in September 2025. A post-mortem examination revealed she had an undiagnosed heart condition, but also indicated that a drop in blood sugar caused by the drug might have triggered the complication. The incident marks one of a growing number of deaths linked to weight-loss drugs. Official figures show that in the UK, 216 people have died due to possible side effects of such medications, though it is unclear whether the drugs were the primary cause. Among these cases, the death of Caroline Savage stands out. A 73-year-old grandmother from Norfolk, Caroline began taking the jab in 2024 after struggling with weight loss for years. She also had lipedema, a condition causing excess fat buildup in the legs, hips, and arms, which Mounjaro has been shown to alleviate. Within four months, Caroline had lost two stone. However, in October 2024, she developed severe stomach pain and collapsed at home. She later died in hospital. The cause of death was identified as faecal peritonitis, a condition where faecal matter leaks from the intestines. This outcome has not previously been associated with weight-loss drugs, raising concerns about potential risks for others using similar treatments. Dr Ellie, a medical professional, warns that many Britons on these medications could be at risk. Constipation, a common side effect, is often not life-threatening but can lead to serious complications. Around one in five adults experiences constipation, with a third of those over 60 affected. Poor diet is a major contributor, with less than 5 percent of Britons consuming the recommended daily intake of 30 grams of fibre. Dehydration and the slowing of the digestive system caused by weight-loss drugs further exacerbate the issue. Long-term constipation can put pressure on the bowel lining, increasing the risk of a tear and allowing faeces to enter the abdominal cavity. Older individuals are particularly vulnerable. Dr Ellie emphasizes that changing dietary habits is key to preventing these issues. Foods rich in fibre, such as kiwis, prunes, nuts, seeds, pulses, legumes, oats, and certain vegetables, are recommended. Drinking at least six glasses of water daily, or more in hot weather, is also advised. Regular physical activity, including walking, running, and swimming, can help ease constipation. For those using weight-loss injections, Dr Ellie highlights the importance of not rushing to increase the dosage. Patients typically start on a low dose, gradually moving to higher levels over several months. It is during these transitions that the most uncomfortable symptoms, including constipation, tend to occur. Taking additional weeks to allow the body to adjust to the medication may reduce side effects. Alternatively, individuals who feel they are making satisfactory progress may choose not to increase their dose at all. These recommendations aim to minimize risks while supporting effective weight management.